Generation Bio Co expected to post a loss of 47 cents a share - Earnings Preview

Generation Bio

11/08/2021 03:38

* Generation Bio Co  GBIO.OQ   GBIO.O  is expected to show a no
change in quarterly revenue when it reports results on August 11
(estimated). 
​* Refinitiv's mean analyst estimate for Generation Bio Co is
for a loss of 47 cents per share. For the same quarter last
year, the company reported a loss of $1.50 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Generation Bio
Co is $39​, about 40.3% above​ its last closing price
of $23.29. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.45       -0.45      -0.46     Missed  -2.2
 Dec. 31 2020  -0.48       -0.50      -0.27     Beat    46.4
 Sep. 30 2020  -0.46       -0.45      -0.46     Missed  -1.7​
 Jun. 30 2020  -0.60       -0.60      -1.50     Missed  -149
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 11 at 02:38 GMT.  All
figures in US dollars unless otherwise stated